MedTrace Logo

Fatty Acids During Pregnancy and Lactation and Body Fat Mass in Newborns

NCT00362089 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208

Last updated 2014-02-04

No results posted yet for this study

Summary

Pregnant and lactating women receive n-3 fatty acids starting from week 15 of gestation until 4 months post-partum (pp) in comparison to a control group, who only gets information about adequately healthy nutrition during pregnancy and lactation.

The amount of fat in newborns is measured through skinfold thickness, ultrasound, and magnetic resonance imaging (MRI).

It is hypothesised that a reduction in arachidonic acid intake and an increase of n-3 LC PUFAs (long chain polyunsaturated fatty acids) via supplements containing docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) could lead to less expansive fat tissue development in the first year of life.

Conditions

Interventions

DIETARY_SUPPLEMENT

Marinol D-40

Marinol D-40, three capsules per day, from 15th week of gestation until 4th month of lactation

Sponsors & Collaborators

  • Else Kröner-Fresenius-Foundation; International Unilever-Foundation; Danone Research

    collaborator UNKNOWN

  • EU funding by EARNEST consortium;German Ministry of Education and Research GF-GFGI01120708)

    collaborator UNKNOWN

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Hans Hauner, Prof. · Else Kröner-Fresenius-Zentrum für Ernährungsmedizin, Technische Universität München

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00362089 on ClinicalTrials.gov